References
- Kronz J D, Westra W H, Epstein J I. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999; 86: 2426–2435
- Cook I S, McCormick D, Poller D N. Referrals for second opinion in surgical pathology: implications for management of cancer patients in the UK. Eur J Surg Oncol 2001; 27: 589–594
- Rosen P P. Consultations and second opinions in breast pathology. Rosen's Breast Pathology. 2nd ed, P P Rosen. Lippincott Williams and Wilkins, Philadelphia 2001; xv–xviii
- Weidner N. Breast diseases. The Difficult Diagnosis in Surgical Pathology, N Weidner. WB Saunders Company, Philadelphia 1996; 625–679
- Leslie K O, Fechner R E, Kempson R L. Second opinions in surgical pathology. Am J Clin Pathol 1996; 106: S58–S64
- Tan S M, Evans A J, Lam T P, Cheung K L. How relevant is breast cancer screening in the Asia/Pacific region?. Breast 2006; 16: 113–119
- Tan P H. Pathology of ductal carcinoma in situ of the breast: a heterogeneous entity in need of greater understanding. Ann Acad Med Singapore 2001; 30: 671–677
- Dabbs D J. Immunocytology, Diagnostic Immunohistochemistry. Churchill Livingstone, Philadelphia 2006; 546–553, 632–6
- Yaziji H, Barry T. Diagnostic immunohistochemistry: what can go wrong?. Adv Anat Pathol 2006; 13: 238–245
- Wood B, Junckerstorff R, Sterrett G, Frost F, Harvey J, Robbins P. A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions. Pathology 2007; 39: 391–395
- Ross J S, Fletcher J A. The her-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist 1998; 3: 237–252
- NHS Cancer Screening Programmes and The Royal College of Pathologists. Pathology Reporting of Breast Disease. NHSBSP, London 2005; 41–87, NHSBSP Publication no. 58
- Ellis I O, Humphreys S, Michell M, Pinder S E, Wells C A, Zakhour H D. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 2004; 57: 897–902
- Going J J, Mallon E A, Leake R E, Bartlett J M, Gusterson B A. What a clinician needs from the pathologist: evidence-based reporting in breast cancer. Eur J Cancer 2001; 37: S5–17
- Anderson T J, Farzana S, Ellis I O. Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. Hum Pathol 2002; 33: 365–371
- Tavassoli F A, Devilee P. Pathology and Genetics: Tumours of the Breast and Female Genital Organs. IARC WHO Classification of Tumours. IARC Press, Lyon 2003; 9–89
- Newman P, Bilous M, Boyages J. Is centralized histopathology review necessary for screen-detected breast lesions?. Breast 1999; 8: 320–327
- Harvey J M, Sterrett G F, McEvoy S, et al. Pathology reporting of breast cancer: trends in 1989–1999, following the introduction of mammographic screening in Western Australia. Pathology 2005; 37: 341–346
- Masood S. The expanding role of pathologists in the diagnosis and management of breast cancer: worldwide excellence in breast pathology program. Breast J 2003; 9(Suppl)S94–S97
- Parham D M, Coleman D, Kodikara S, et al. The NHS breast screening programme (pathology EQA: experience in recent years relating to issues involved in individual performance appraisal). J Clin Pathol 2005; 59: 130–137
- Vargas H I, Anderson B O, Chopra R, et al. Diagnosis of breast cancer in countries with limited resources. Breast J 2003; 9(Suppl)S60–S66
- Collins L C, Connolly J L, Page D L, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol 2004; 28: 126–131
- Ponsky J L, Gliga L, Reynolds S. Medullary carcinoma of the breast: an association with hormone negative receptors. J Surg Oncol 1984; 25: 76–78
- Rosen P P. Rosen's Breast Pathology. 2nd ed. Lippincott Williams and Wilkins, Philadelphia 2001
- Putti T C, Pinder S E, Elston C W, Lee A HS, Ellis I O. Breast pathology practice: most common problems in consultation service. Histopathology 2005; 47: 445–457
- Lerwill M F. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004; 28: 1076–1091
- Simpson P T, Gale T, Gulford L G, Reis-Filho J S, Lakhani S. The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003; 5: 258–262
- Koerner F, Maluf H. Uncommon morphologic patterns of lobular neoplasia. Ann Diagn Pathol 1999; 3: 249–259
- Tan P H, Tse G MK, Bay B H. Mucinous breast lesions: diagnostic challenges. J Clin Pathol 2008; 61: 11–19
- Akhilesh M, Somani A, Tan P H. Biological markers to predict phyllodes tumours in needle core biopsies. Pathology Int 2007; 57(Suppl 1)A5
- Tan P H, Jayabaskar T, Chuah K L, et al. Phyllodes tumours of the breast: the role of pathologic parameters. Am J Clin Pathol 2005; 123: 529–540
- Loh H L, Kumarasinghe P, Tan P H. Test and Teach: Recurrent breast lumps in a Chinese woman. Adenomyoepithelioma of the breast. Pathology 2004; 36: 269–272
- Foxcroft L M, Evans E B, Porter A J. The diagnosis of breast cancer in women younger than 40. Breast 2004; 13: 297–306
- Fernandopulle S M, Ang P C, Tan P H. Breast carcinoma in women 35 years and younger: a pathological study. Pathology 2006; 38: 219–222
- Winchester D P. Breast cancer in young women. Surg Clin North Am 1996; 26: 279–287